<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter.</PublisherName>
				<JournalTitle>Asian Pacific Journal of Cancer Prevention</JournalTitle>
				<Issn>1513-7368</Issn>
				<Volume>15</Volume>
				<Issue>2</Issue>
				<PubDate PubStatus="epublish">
					<Year>2014</Year>
					<Month>02</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Clinical Value of Dual-phase 18F-FDG SPECT with Serum Procalcitonin for Identification of Etiology in Tumor Patients with Fever of Unknown Origin</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>683</FirstPage>
			<LastPage>686</LastPage>
			<ELocationID EIdType="pii">28645</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>1970</Year>
					<Month>01</Month>
					<Day>01</Day>
				</PubDate>
			</History>
		<Abstract>&lt;br/&gt;&lt;b&gt;Objective&lt;/b&gt;: The purpose of the study was to evaluate clinical value of dual-phase 18F-FDG SPECT withserum procalcitonin (PCT) in identifying cancers in patients with fever of unknown origin (FUO). &lt;br/&gt;&lt;b&gt;Methods&lt;/b&gt;:PCT test and dual-phase 18F-FDG SPECT were sequentially performed on 50 consecutive patients with FUO.Two radiologists evaluated all 18F-FDG SPECT data independently. A consensus was reached if any differenceof opinions existed. Final diagnosis was based on a comprehensive analysis of results for the PCT test, dualphase18F-FDG SPECT and bacterial cultivation, regarded as a gold standard. &lt;br/&gt;&lt;b&gt;Results&lt;/b&gt;: Among 50 patients, 34demonstrated PCT ≥ 0.5 μg/L. Coincidence imaging showed in 37 patients with inflammatory lesions, and 13 withmalignancy. Finally, 36 bacterial, 1 fungal and 1 viral infections, as well as 12 cancerous fevers were confirmed bydual-phase 18F-FDG SPECT with PCT, combined with bacterial cultivation and clinical follow-up. &lt;br/&gt;&lt;b&gt;Conclusion&lt;/b&gt;:Our study demonstrated that dual-phase 18F-FDG SPECT in association with PCT could be a valuable tool fordiagnosis in tumor patients with FUO.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Tumor cases</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">fever of unknown origin</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">prediction</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">FDG SPECT</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">serum procalcitonin</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.waocp.org/article_28645_cb148ae8ccc99da9d0f509365ab17813.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
